|
|
News Breaks
|
October 1, 2009
|
| 17:28 EDT |  | TGEN |
| theflyonthewall.com: | Targeted Genetics regains Nasdaq compliance | | Targeted Genetics Corporation announced that, on September 28, the Nasdaq granted the company's request to remain listed on The Nasdaq Capital Market. The company's continued listing is subject to regaining compliance with the Nasdaq listing requirements by evidencing shareholders' equity of $2.5M on or before January 19, 2010 and achieving a closing bid price of $1.00 or more for a minimum of 10 consecutive trading days on or before February 8, 2010, as well as maintaining compliance with all other requirements for continued listing on the Nasdaq Capital Market. In addition, the company must inform the Nasdaq panel if the company determines not to pursue a reverse stock split as a means, if necessary, to enable the company to regain compliance with the $1.00 share price requirement. If the company does not satisfy the foregoing conditions, the Nasdaq panel will issue a final determination to delist the company's common stock and will suspend trading of the company's shares effective on the second business day after the date of the Panel's final determination. :theflyonthewall.com |
|
|
News For TGEN From The Last 14 Days Check below for free stories on TGEN the last two weeks.
| Sign up for a free trial to see the rest of the stories you've been missing. |
There are no results for these search parameters.
|
|
|
|
